Conditions: Acne Vulgaris Post Inflammatory Hyperpigmentation
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 21
Healthy volunteers: yes

Brief summary:
This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and Weeks 4, 8, and 16. All subjects will receive Onexton at Baseline and be instructed to apply the gel once daily to the face. The investigators will evaluate Investigator Global Assessment of acne (IGA), total lesion count, inflammatory lesion count, non-inflammatory lesion count, Investigator Global Assessment of Post-Inflammatory Hyperpigmentation and distribution of Post-Inflammatory Hyperpigmentation, adverse events and concomitant medications.

Detailed description:

Arms:
arm 1: Onexton gel will be supplied to all subjects and applied once daily to the face

Interventions: intervention 1: ONEXTON Topical Gel
Intervention descriptions: intervention 1: Onexton gel applied once daily to face

Protocol document:
Prot_SAP_001.pdf: 

































ICF_000.pdf: